Examining the viability of modern endoscopic endonasal surgery as a first-line treatment for macroprolactinomas: a multicentric study on the results and significance of the highest preoperative prolactin level in predicting long-term surgical outcome

The authors found that modern EES in multidisciplinary centers was a low-morbid option for patients with macroprolactinoma. Remission rates were consistent with those of recent studies with variably sized prolactinomas, and recurrence rates were low. Although not universally definitive for macroprolactinomas, early EES can be offered for patients with the highest preoperative prolactin levels below 150 µg/L who are unwilling to receive long-term medication. Radiological criteria alone should not be the sole factor in surgical decision-making.

Authors

Institutions

Publication Details

Journal
Journal of neurosurgery
Published
2025-06-06
DOI
https://doi.org/10.3171/2025.1.jns241645
Citations
1
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Examining the viability of modern endoscopic endonasal surgery as a first-line treatment for macroprolactinomas: a multicentric study on the results and significance of the highest preoperative prolactin level in predicting long-term surgical outcome

Mehdi Khaleghi, Iris C. M. Pelsma, Marco J. T. Verstegen, Amir R. Dehdashti et al.
1 citations
Journal of neurosurgery
Pituitary Gland Disorders and Treatments
1.29
article

Examining the viability of modern endoscopic endonasal surgery as a first-line treatment for macroprolactinomas: a multicentric study on the results and significance of the highest preoperative prolactin level in predicting long-term surgical outcome

Mehdi Khaleghi, Iris C. M. Pelsma, Marco J. T. Verstegen, Amir R. Dehdashti, Leontine E. H. Bakker, Nienke Ruurdje Biermasz, Luma Ghalib, Ingrid M. Zandbergen, Danielle Golub, Daniel M. Prevedello, Alexander F. Küffer, Timothy G. White, Kristin Michelle Huntoon
article en
1 citations

Abstract

The authors found that modern EES in multidisciplinary centers was a low-morbid option for patients with macroprolactinoma. Remission rates were consistent with those of recent studies with variably sized prolactinomas, and recurrence rates were low. Although not universally definitive for macroprolactinomas, early EES can be offered for patients with the highest preoperative prolactin levels below 150 µg/L who are unwilling to receive long-term medication. Radiological criteria alone should not be the sole factor in surgical decision-making.

Journal of neurosurgeryVol. 143(5)
Northwell Health (US), Hofstra University (US), Leiden University Medical Center (NL), The Ohio State University Wexner Medical Center (US)
Openalex Percentile: Top 19%
Pituitary Gland Disorders and Treatments
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.